Patent · US Active

Using programmable DNA binding proteins to enhance targeted genome modification

US10266851B2 · kind B2 · utility

96Cited by
7References
18Claims
0Family size

Assignee

Inventor

Key dates

Filing dateFeb 20, 2017
Grant dateApr 23, 2019
Priority date
Expiry dateFeb 20, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N15/102
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Compositions and methods for using programmable DNA binding proteins to increase the efficiency and/or specificity of targeted genome modification or to facilitate the detection of specific genomic loci in eukaryotic cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.